The Legal Examiner Mark The Legal Examiner Mark The Legal Examiner Mark search twitter facebook feed linkedin instagram google-plus avvo phone envelope checkmark mail-reply spinner error close
Skip to main content

The FDA has called on Johnson & Johnson, the manufacturer of Ditropan, to publish a stronger warning regarding the potential hallucinogenic risks for children and the elderly. Ditropan is used for bladder problems. The drug, also known as oxybutynin, already lists insomnia, nervousness, confusion and other central nervous system risks on its label, but FDA staff reviewers said more explicit cautions are needed.

Comments are closed.

Of Interest